首页> 美国卫生研究院文献>BMJ Open Access >Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

【2h】

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

机译：玻璃体腔注射阿柏西普注射液治疗湿性年龄相关性黄斑变性的疗效和安全性：VIEW 2研究的日本亚组的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/aimsTo evaluate efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with wet age-related macular degeneration (wAMD) from the VIEW 2 trial.

机译：背景/目的从VIEW 2试验中评估玻璃体腔注射阿柏西普（IVT-AFL）在日本湿性年龄相关性黄斑变性（wAMD）患者中的疗效和安全性。

著录项

期刊名称 BMJ Open Access
作者
Yuichiro Ogura; Hiroko Terasaki; Fumi Gomi; Mitsuko Yuzawa; Tomohiro Iida; Miki Honda; Koichi Nishijo; Olaf Sowade; Tetsushi Komori; Ursula Schmidt-Erfurth; Christian Simader; Victor Chong;
展开▼
作者单位

展开▼
年(卷),期 -1(99),1
年度 -1
页码 92–97
总页数 6
原文格式 PDF
正文语种
中图分类
关键词
Angiogenesis Clinical Trial Macula Neovascularisation Retina;

机译：血管生成;临床试验;黄斑;新生血管形成;视网膜;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study [J] . Ogura Yuichiro, Terasaki Hiroko, Gomi Fumi, British journal of ophthalmology . 2015 ,第1期

机译：玻璃体腔注射阿柏西普注射液在湿性年龄相关性黄斑变性中的疗效和安全性：VIEW 2研究的日本亚组的结果
2. EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT AND RANIBIZUMAB IN ASIAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Subgroup Analyses From the VIEW Trials [J] . Wong Tien Yin, Cheung Chui Ming Gemmy, Lai Timothy Y. Y., Retina . 2019 ,第3期

机译：含有术治疗患者术治疗术治疗的亚洲血管时代相关黄斑亚组分析的亚洲患者的嗜疗性和Ranibizumab的疗效和安全性
3. A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] [J] . Clinical ophthalmology . 2017 ,第8期

机译：由研究者发起的单臂研究，用于玻璃体腔注射阿柏西普注射液对先前接受过兰尼单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效，安全性和耐受性（ASSESS研究）：12个月分析[更正]
4. Knowledge discovery in ophthalmology: analysis of wet form of Age-related Macular Degeneration treatment outcomes [C] . Magdalena Ulinska, Emanuel Tataj, Jan Mulawka, Conference on photonics applications in astronomy, communications, industry, and high-energy physics experiments . 2009

机译：眼科知识发现：与年龄相关的黄斑变性的湿润形式治疗结果分析
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study [O] . Michel Weber, Laurent Velasque, Florence Coscas, 2019

机译：在整个法国的常规临床实践中玻璃体腔内使用阿柏西普治疗与年龄相关的湿性黄斑变性患者的有效性和安全性：RAINBOW研究的12个月结果
7. Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: Outcomes in the Japanese subgroup of the VIEW 2 study [O] . Ogura, Y, Terasaki, H, Gomi, F, 2014

机译：玻璃体腔注射阿柏西普注射液治疗湿性年龄相关性黄斑变性的有效性和安全性：VIEW 2研究的日本亚组的结果

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

摘要

著录项

相似文献

相关主题

期刊订阅